DK0754229T3 - Afamin: et humant serum albumin-lignende protein - Google Patents

Afamin: et humant serum albumin-lignende protein

Info

Publication number
DK0754229T3
DK0754229T3 DK95915503T DK95915503T DK0754229T3 DK 0754229 T3 DK0754229 T3 DK 0754229T3 DK 95915503 T DK95915503 T DK 95915503T DK 95915503 T DK95915503 T DK 95915503T DK 0754229 T3 DK0754229 T3 DK 0754229T3
Authority
DK
Denmark
Prior art keywords
human serum
protein
serum albumin
afamin
human
Prior art date
Application number
DK95915503T
Other languages
Danish (da)
English (en)
Inventor
Henri Stephen Lichenstein
David Edwin Lyons
Mark Matsuo Wurfel
Samuel Donald Wright
Original Assignee
Amgen Inc
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, Univ Rockefeller filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0754229T3 publication Critical patent/DK0754229T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95915503T 1994-03-31 1995-03-31 Afamin: et humant serum albumin-lignende protein DK0754229T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/222,619 US5652352A (en) 1994-03-31 1994-03-31 Afamin: a human serum albumin-like gene
PCT/US1995/004075 WO1995027059A1 (fr) 1994-03-31 1995-03-31 L'afamine, une proteine albuminoide serique humaine

Publications (1)

Publication Number Publication Date
DK0754229T3 true DK0754229T3 (da) 1999-07-19

Family

ID=22832990

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95915503T DK0754229T3 (da) 1994-03-31 1995-03-31 Afamin: et humant serum albumin-lignende protein

Country Status (11)

Country Link
US (2) US5652352A (fr)
EP (1) EP0754229B1 (fr)
JP (1) JPH09511399A (fr)
AT (1) ATE173014T1 (fr)
AU (1) AU691607B2 (fr)
CA (1) CA2186516A1 (fr)
DE (1) DE69505804T2 (fr)
DK (1) DK0754229T3 (fr)
ES (1) ES2123973T3 (fr)
MX (1) MX9604402A (fr)
WO (1) WO1995027059A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410269B1 (en) * 1995-06-07 2002-06-25 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
US20060014143A1 (en) * 1995-06-07 2006-01-19 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
US7208576B2 (en) * 1999-01-06 2007-04-24 Merrimack Pharmaceuticals, Inc. Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
AT407675B (de) * 1999-06-25 2001-05-25 Vita Tech Illmensee Dieplinger Verfahren zur fertilitätsbestimmung von säugetieren, insbesondere von menschen
JP4336771B2 (ja) * 2001-03-09 2009-09-30 モルフォシス アーゲー 血清アルブミン結合部分
AT411014B (de) * 2001-04-30 2003-09-25 Vitateq Biotechnology Gmbh Präparationen von vitamin e in kombination mit afamin
CA2471363C (fr) 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Proteines hybrides d'albumine
CA2489596A1 (fr) * 2002-06-14 2003-12-24 Dyax Corporation Analyse de proteines
JP4492156B2 (ja) * 2004-03-03 2010-06-30 ニプロ株式会社 血清アルブミンドメインを含む蛋白質
AT501348B1 (de) * 2005-01-31 2008-10-15 Vitateq Biotechnology Gmbh Verfahren zur tumordiagnose
US8741662B2 (en) * 2006-06-14 2014-06-03 The Johns Hopkin University Albumin-bound protein/peptide complex as a biomarker for disease
AT505727B1 (de) * 2007-09-04 2009-06-15 Univ Innsbruck Verfahren zur diagnose des metabolischen syndroms
WO2013000992A1 (fr) 2011-06-28 2013-01-03 Vitateq Biotechnology Gmbh Procédé pour le diagnostic de pré-éclampsie
GB2511525A (en) * 2013-03-05 2014-09-10 Randox Teoranta Methods and Compositions for the Diagnosis of Alzheimer's Disease
JP2016188761A (ja) * 2013-08-23 2016-11-04 国立研究開発法人国立国際医療研究センター 糖尿病腎症の発症または発症リスクの検出方法及びキット
EP3037824A1 (fr) 2014-12-22 2016-06-29 Vitateq Biotechnology GmbH Procédé pour la détection et/ou la quantification de l'afamine
EP3239301B1 (fr) * 2014-12-24 2019-09-04 Osaka University Procédé pour la production d'une protéine wnt et son procédé de stockage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1226551B (it) * 1988-07-29 1991-01-24 Sclavo Spa Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico
US6268212B1 (en) * 1993-10-18 2001-07-31 Amgen Inc. Tissue specific transgene expression

Also Published As

Publication number Publication date
CA2186516A1 (fr) 1995-10-12
ES2123973T3 (es) 1999-01-16
MX9604402A (es) 1997-07-31
DE69505804T2 (de) 1999-07-08
ATE173014T1 (de) 1998-11-15
WO1995027059A1 (fr) 1995-10-12
US5767243A (en) 1998-06-16
EP0754229B1 (fr) 1998-11-04
US5652352A (en) 1997-07-29
EP0754229A1 (fr) 1997-01-22
JPH09511399A (ja) 1997-11-18
AU2236795A (en) 1995-10-23
AU691607B2 (en) 1998-05-21
DE69505804D1 (de) 1998-12-10

Similar Documents

Publication Publication Date Title
DK0754229T3 (da) Afamin: et humant serum albumin-lignende protein
DE69131580D1 (de) GDF-1 und UOG1 Proteine
AU8747791A (en) Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
ATE223229T1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
ATE267255T1 (de) Ob proteinderivate mit verlängerter halbwertzeit
DK0807178T3 (da) Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose
DK0705846T3 (da) Höjmolekylære og lavmolekylære fraktioner af von Willebrand-faktor
ATE273388T1 (de) Veränderte menschliche c3-proteine
DE69634077D1 (de) Haemophilus adhäsionsproteinen
MX9602557A (es) Proteinas de higado de mamifero y su uso en oncologia.
DE69524971T2 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
SE9602822D0 (sv) New receptor
DE69734596D1 (de) "smoothened" proteine aus wirbeltieren
ATE278781T1 (de) Tioredioxine h aus zwig und hart-weizen und ähnliche proteine, diese kodierende dna-fragmente und verfahren zu ihrer herstellung
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
WO1996016170A3 (fr) Proteines impliquees dans la regulation de l'adhesion cellule-cellule et leurs utilisations
WO1992011367A3 (fr) Recepteurs lipidiques de micro-organismes et adhesines correspondantes, sequences d'adn codant des adhesines et utilisation desdites adhesines
DE58907373D1 (de) Modifizierte Proteine.
ATE432292T1 (de) Antitumorantikörper, proteine und deren verwendung
SE9604439D0 (sv) New receptor
NZ503256A (en) Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding protein receptors
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.
MX9704110A (es) Nueva proteina de membrana helicobacter pylori p76.